aod9604 peptide dose December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting PDF) Peptides: AOD-9604 & BPC-157
Description
AOD 9604 Side Effects: What Six Clinical Trials Found The safety data on AOD 9604 is stronger than for most investigational peptides, precisely because six formal clinical trials were conducted before development halted
You're currently receiving medication or treatments that affect bone marrow
It is converted by the body into Adenosylcobalamin and Methylcobalamin so they can be absorbed
Consistent Dosage Patients receive a controlled dose with injections, reducing the risk of variability often associated with oral supplements
